Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

BUY
$28.47 - $38.49 $15,772 - $21,323
554 Added 7.3%
8,144 $296,000
Q3 2023

Nov 01, 2023

BUY
$28.28 - $38.36 $12,188 - $16,533
431 Added 6.02%
7,590 $243,000
Q2 2023

Aug 02, 2023

BUY
$17.67 - $31.31 $27,494 - $48,718
1,556 Added 27.77%
7,159 $224,000
Q1 2023

Jun 13, 2024

BUY
$17.13 - $38.52 $249,738 - $561,583
14,579 New
14,579 $332,000
Q4 2022

Feb 01, 2023

SELL
$29.44 - $37.31 $27,438 - $34,772
-932 Reduced 14.26%
5,603 $191,000
Q3 2022

Nov 10, 2022

SELL
$28.84 - $38.92 $213,877 - $288,630
-7,416 Reduced 53.16%
6,535 $211,000
Q2 2022

Aug 11, 2022

BUY
$33.25 - $45.11 $168,012 - $227,940
5,053 Added 56.79%
13,951 $535,000
Q1 2022

May 12, 2022

BUY
$40.68 - $49.72 $45,805 - $55,984
1,126 Added 14.49%
8,898 $388,000
Q4 2021

Feb 11, 2022

SELL
$43.21 - $57.6 $20,567 - $27,417
-476 Reduced 5.77%
7,772 $379,000
Q3 2021

Nov 12, 2021

SELL
$52.8 - $60.32 $792 - $904
-15 Reduced 0.18%
8,248 $464,000
Q2 2021

Aug 12, 2021

BUY
$51.29 - $59.15 $423,809 - $488,756
8,263 New
8,263 $460,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $477M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.